Connect with us


RICHARD BOHANNON – Improvising Physical Therapy Treatment




Health is real wealth. One who remains fit aims to live a great life while participating in various activities without facing pain and other physical health issues. Fitness is the secret to a balanced life. No one wants to be dependent on others. Everyone expects to perform day-to-day tasks without any hassle. Those who are physically fit can easily participate in the activities that they need to indulge in regularly. But various physical health issues, such as pain in the knees, back, neck, and weak muscles, prevent individuals from playing sports, taking walks, and doing their other favorite tasks. These individuals often take painkillers to get relief. Unfortunately, these meds are not the permanent solution. One needs to identify the root cause, remove it, and get relief from the pain permanently. Physical therapy treatments are a good choice for such individuals in these instances. The physical therapists educate the patients regarding movement issues, provide them therapy, and suggest the right exercise plan to get rid of pain and help them gain fitness as soon as possible. Such therapists have changed individuals’ lives by improving their lifestyle and physical fitness through physical therapy treatments. Not just them but the researchers who have been putting effort into finding out the right solution for various chronic pain, severe injuries, and weak muscle issues. One prominent example comes from an American physical therapy clinician, scholar, educator, and researcher, Dr. Richard W. Bohannon. He has multiple achievements in terms of improvising physical therapy as a researcher and guiding physical therapy students through his studies.

As a researcher, Richard Bohannon has brought various innovations in the physical therapy management of patients. The industry needs more and more research to improve individuals’ physical health and lifestyle. In addition to producing new treatments, research ensures that certain treatments are utilized in the most appropriate ways. Diverse research helps find answers to the mystery of science, fill information gaps, and change how therapists and other healthcare professionals perform their duties.

An academic research unit in colleges or universities strongly impacts the effectiveness of physical therapy treatments provided in the clinics. The combination of research and the clinic’s work strongly affects how treatments are developed throughout the country. Throughout the years, multiple components of research and innovations have improved the healthcare industry as a whole. Like any other doctor’s field, physical therapy is dependent on clinical research. Despite gaining physiotherapy qualifications, the professional therapist needs to constantly seek new evidence to inform care. 

Born on December 29, 1953, Richard Bohannon has contributed research to improve physical therapy for over 30 years. Richard Bohannon presently serves as a Principal of Physical Therapy Consultants in North Carolina. He also has worked as Editor in Chief of various journals, including Archives of Gerontology and Geriatrics, the Journal of the Geriatric Physical Therapy, and the Journal of Human Muscle Performance. As a scholar, Bohannon has been cited more than 42,000 times.

Bohannon was interested in impacting the physical therapy profession from his college days. He attended the University of North Carolina at Chapel Hill, where she completed his BS and MS in Physical Therapy. Richard’s strong educational background has made him a reputable scholar and researcher today. He earned his Doctor of Educated from North Carolina State University and also received a Doctor of Physical Therapy from Boston University. For the past few years, he has been enrolled in a Ph.D. program at the University of Portsmouth.

Being a scholar and educator, Bohannon has worked on multiple publications. In fact, he has authored more than 500 peer-reviewed publications. As an educator, Richard Bohannon has served as a physical therapy professor for more than two decades. He served as a full professor at the University of Connecticut in Storrs. During his tenure there, he served as an Acting Director twice. He also served as a full- professor in other institutions, including the University of Connecticut Health Center in Farmington and Campbell University in North Carolina.

Richard Bohannon has earned multiple awards while contributing to physical therapy literature and research. He won the Helen Hislop Award in 1996 for his results-oriented contributions to Professional Literature. Then in 2005, he received the Marian Williams Award for his research in physical therapy. He also received the Jules Rothstein Golden Pen Award in 2008 for his scientific writing. All the awards were given by the American Physical Therapy Association. Richard Bohannon is also a member of various societies, including the American Society of Neurorehabilitation, American Physical Therapy Association, Stroke Council of the American Heart Association, and Gerontological Society of America.

Michelle has been a part of the journey ever since Bigtime Daily started. As a strong learner and passionate writer, she contributes her editing skills for the news agency. She also jots down intellectual pieces from categories such as science and health.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


The Most Compatible Solution to the Human Body from Turkish Scientists for Joint Pains Warned by The World Health Organization!




Degeneration of the joints significantly complicates daily life.

The World Health Organization (WHO) predicts that by 2050, 130 million people worldwide will suffer from joint pain and osteoarthritis. According to the World Health Organization, by 2050, 40 million people will lose function due to osteoarthritis.

The USA is the country with the highest prevalence of osteoarthritis in the world. More than half (18.7 million people) of adults with osteoarthritis in the United States are of working age (18-64 years). For this reason, osteoarthritis also causes a significant loss of workforce.

Against joint pain and osteoarthritis Scientists have made an important discovery. Developed with hybrid technology, HYDRAVIC received full marks from health authorities.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.


Against joint pain and osteoarthritis, which the world is looking for a cure for, scientists have made an innovative development in intra-articular fluids. Turkish scientists have developed an intra-articular injection with the most compatible gel form with the hybrid production technology. The product, which was launched under the HYDRAVIC brand, attracts great attention all over the world.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.


HYDRAVIC, one of the first intra-articular injections with hybrid production technology in Turkey, stands out with its patient satisfaction. Stating that HYDRAVIC minimizes the wear on the cartilage and slows down the pressure created by the body on the cartilage, Prof. Dr. Serdar Sezer said, “HYDRAVIC was developed with inspiration from the complex structure of hyaluronic acid in the body. Patient satisfaction is quite good. Hybrid technology is a system that has been applied for the first time in Turkey, like its examples in the world. HYDRAVIC prevents patients from complaining of pain for up to 6-8 months.” 


Drawing attention to the importance of hybrid technology used in the production of HYDRAVIC, Professor Serdar Sezer “One of the features of hybrid technology is that it creates a triggering effect for the product to produce hyaluronic acid while being excreted from the body. This has been demonstrated in in-vitro and in-vivo experiments. Clinical long-term responses are very good. In our studies while developing these products, we have observed studies that have a longer duration of action with our innovative approach that repeats the results proven in the world. After its effectiveness has been proven, we are happy to introduce such a product to the market in the injection market, where we are one of the leading manufacturers in the field. We apply similar approaches across all our product models.” uses expressions.

Stating that they minimize the pain experienced by the patients during the injection, Professor Sezer said, “What makes HYDRAVIC different from other products is its technology. It is a product that does not make the patient feel very low or no pain during the injection and relieves the patient’s pain in a short time. In this technology, in addition to the molecular interaction, post-injection pain and swelling, etc., due to the production of the product in aseptic technical infrastructure. We minimize such complaints as possible.”


Stating that Europe’s largest pharmaceutical and medical device R&D Center in the field of biomaterials was established in Turkey, Professor Sezer said, “To produce these kinds of products, the well-equipped infrastructures are required very serious costs. Many companies do not want to invest in such product groups, which have high infrastructure costs and are difficult to produce. With the new legislation, the costs increase significantly. We reach an annual capacity of 5.4 million units in 2023 in the HYDRAVIC production line, where we have achieved great success in the medical market.” he said.

Continue Reading